Prognostic factors and individualized nomograms predicting overall survival in stage IV rectal cancer patients with different metastatic status: a SEER-based study.

Ge, Heming; Zhou, Zhongyi; Li, Yuqiang; Wang, Dan; Güngör, Cenap

Ge, Heming; Zhou, Zhongyi; Li, Yuqiang; Wang, Dan; Güngör, Cenap.

Afiliación

Ge H; Department of General Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Zhou Z; Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
Li Y; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Wang D; Department of General Surgery, Xiangya Hospital, Central South University, Changsha, China.
Güngör C; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.

Transl Cancer Res ; 11(9): 3141-3155, 2022 Sep.

Article en En | MEDLINE | ID: mdl-36237239

Palabras clave

Metastatic rectal cancer (mRC); SEER database; different metastatic status; nomogram; overall survival (OS)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google